Advancing the Management of Diabetes: An Update on New Guidelines and Treatment Options

Samuel L. Ellis, PharmD, BCPS
Published Online: Thursday, May 15, 2014
Follow Pharmacy_Times:
This activity is supported by educational grants from AstraZeneca LP, Merck Sharp & Dohme, and Novo Nordisk, Inc.

Advancing the Management of Diabetes: An Update on New Guidelines and Treatment Options

Samuel L. Ellis, PharmD, BCPS
Associate Professor
Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, Colorado
 
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose.

Faculty 
Samuel L. Ellis, PharmD, BCPS
 
Pharmacy Times Office of Continuing Professional Education
Planning Staff—David Heckard; Maryjo Dixon, RPh; Donna Fausak; and Nathalie Harden

Pharmacy Times Editorial Staff
Bea Riemschneider and Kirk McKay

An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Objectives
At the conclusion of this educational activity, participants should be able to:
  • Discuss current management of type 2 diabetes mellitus (T2DM), including updated clinical practice guidelines and the incorporation of new therapeutic classes into practice recommendations.
  • Identify and develop strategies that address clinical inertia and other barriers to optimal management of T2DM.
  • Summarize how the pharmacist’s role is evolving and identify methods to improve diabetes management.
Target Audience: Pharmacists
Type of activity: Knowledge
Release date: May 9, 2014
Expiration date: May 9, 2016
Estimated time to complete activity: 1.5 hours
Fee: Free

Click here to view this activity.

Description: Pharmacy Times/Ascend Media Office of Continuing Professional EducationPharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-14-045-H01-P. The activity is available for CE credit through May 9, 2016.

Related Articles
Women diagnosed with polycystic ovary syndrome are more likely to develop heart disease, diabetes, and other chronic conditions than those without the hormone disorder.
Not every patient requires an aspirin a day.
The FDA announced today that it will permit the marketing of a mobile medical app that will help patients with diabetes share data from a continuous glucose monitor with other individuals.
The introduction of sodium glucose transporter 2 inhibitors has marked a turning point in the management of patients with both type 1 and type 2 diabetes.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$